Author:
Caballero-Calabuig Elisa,Cano-Terol Carmen,Sopena-Monforte Ramón,Reyes-Ojeda Dolores,Abreu-Sánchez Pedro,Ferrer-Rebolleda José,Sopena-Novales Pablo,Plancha-Mansanet Carmen,Félix-Fontestad Jesús
Publisher
Springer Science and Business Media LLC
Subject
Radiology, Nuclear Medicine and imaging,General Medicine,Radiology, Nuclear Medicine and imaging,General Medicine
Reference25 articles.
1. Mazzaferri EL, Kloos RT. Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 2001;86(4):1447–63.
2. National Comprehensive Cancer Network (NCCN). Thyroid carcinoma. Clinical practice guidelines in oncology, version 1. Fort Washington: NCCN; 2005.
3. Robbins RJ, Schlumberger MJ. The evolving role of 131I for the treatment of differentiated thyroid carcinoma. J Nucl Med 2005;46S:28S–37S.
4. Schlumberger M, Berg G, Cohen O, Duntas L, Jamar F, Jarzab B, et al. Follow up of low-risk patients with differentiated thyroid carcinoma: an European Perspective. Eur J Endocrinol 2004;150:105–12.
5. Mazzaferri EL, Robbins RJ, Spencer CA, Braverman LE, Pacini F, Wartofsky L, et al. A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 2003;88:1433–41.
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献